Biotechnology – Page 7

IGM Biosciences Shifts Focus to Autoimmune Diseases Amid Leadership Changes

11 months ago talkbio0Tagged Arthritis, Autoimmune Diseases, Biosciences, Biotechnology, C-suite exits, Immunoglobulin M, Immunology

IGM Biosciences, autoimmune diseases, C-suite exits, biotechnology, immunology, arthritis, lupus

Amgen’s Mixed Results: A Tale of Two Readouts in Eczema and Myasthenia Gravis Trials

11 months ago talkbio0Tagged amgen, Biotechnology, Clinical Trials, Drug Industry, Eczema, Myasthenia Gravis, Rocatinlimab

Amgen, Clinical Trials, Eczema, Myasthenia Gravis, Rocatinlimab, Uplizna, Biotechnology, Pharmaceutical Industry

Upstream Biotech Prepares to Join the Wave of Biotech IPOs with Inflammation-Focused Therapies

11 months ago talkbio0Tagged biotech, Biotechnology, healthcare innovation, Industry, Inflammation-Focused Therapies, IPOs, offerings, public entity, Upstream

Biotech IPOs, Upstream Biotech, Inflammation-focused therapies, Biotechnology industry, Public offerings, Healthcare innovation

AstraZeneca Unveils In-House ADCs, Rivaling AbbVie and Pfizer’s Cancer Therapies

11 months ago talkbio0Tagged AbbVie, Antibody-Drug, Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Daiichi, Immunostimulating conjugate (antigen), Neoplasms, Pfizer, Sankyo

AstraZeneca, Daiichi Sankyo, Antibody-Drug Conjugates (ADCs), Cancer Therapies, AbbVie, Pfizer, Oncology, Biotechnology

Moderna Revamps R&D Strategy with $1.1B Cuts and Pipeline Overhaul

11 months ago talkbio0Tagged Biotechnology, development aspects, Drug Industry, Financial cost, Moderna, R&D, research

Moderna, R&D cuts, pipeline overhaul, biotechnology, pharmaceutical industry, cost reduction, research and development.

BIOSECURE Act Clears House Hurdle, Heads to Senate for Vote on Restricting Chinese Biotech Ties

12 months ago talkbio0Tagged BIOSECURE, Biotech Companies, Biotechnology, Chinese Language, Drug Industry, drug supply chain, innovation, National Security, Risk, Senate, United States, US House of Representatives, Voting

BIOSECURE Act, House of Representatives, Senate Vote, Chinese Biotech Companies, National Security Risks, U.S. Pharmaceutical Industry, Biotechnology Innovation, Drug Supply Chain

Voyager Therapeutics Secures $100M Upfront Payment in Expanded Gene Therapy Partnership with Novartis

12 months ago talkbio0Tagged Biotechnology, capsid discovery, gene therapy, Huntington Disease, Novartis, Spinal Muscular Atrophy, Tracer

Gene therapy, Novartis, Voyager Therapeutics, Huntington’s disease, Spinal muscular atrophy (SMA), TRACER capsid discovery platform, Biotechnology collaboration

Unveiling the Future of Biotech: Top 11 Startups to Watch in 2024

12 months ago talkbio0Tagged biotech, biotech startups, Biotechnology, Industry, innovation, trends qualifier

Biotech startups, Top biotech companies, Biotechnology industry, Emerging biotech trends, Biotech innovation, Biotech awards

Novartis and Versant Ventures Launch Borealis Biosciences to Develop RNA Medicines for Kidney Diseases

1 year ago talkbio0Tagged Biosciences, Biotechnology, Borealis, Kidney, Kidney Diseases, Novartis, RNA, RNA medicines, startup, Ventures, Versant, xRNA

Borealis Biosciences, Novartis, Versant Ventures, RNA medicines, kidney diseases, xRNA technology, biotechnology, startup, kidney research, RNA therapeutics.

Navigating Challenges and Opportunities in the 2024 Life Sciences Industry Outlook

1 year ago talkbio0Tagged Artificial Intelligence, Attitude, Biotechnology, Changing, drug price, Life Sciences Industry, regulatory, shortage, Supply Chain Security, Talent

Life Sciences Industry, 2024 Outlook, Biotechnology, Medical Devices, Artificial Intelligence, Drug Pricing, Regulatory Changes, Supply Chain Security, Talent Shortage